Analysis of the Proliferative Activity in Lung Adenocarcinomas with Specific Driver Mutations

Publication date: Available online 2 January 2018
Source:Pathology - Research and Practice
Author(s): Mark Kriegsmann, Alexander Harms, Daniel Kazdal, Sebastian Fischer, Albrecht Stenzinger, Jonas Leichsenring, Roland Penzel, Rémi Longuespée, Katharina Kriegsmann, Thomas Muley, Seyer Safi, Arne Warth
In the last decade it became evident that many lung adenocarcinomas (ADC) harbor key genetic alterations such as KRAS, EGFR or BRAF mutations as well as rearrangements of ROS1 or ALK that drive these tumors. In the present study we investigated whether different driver mutations of ADC result in different proliferation rates, which might have clinical impact, including resistance to therapy, recurrence and prognosis.



from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2DVakSf